InfanDx

Koln, Germany Founded: 2010 • Age: 16 yrs
In-vitro diagnostic products for newborn acute care conditions are developed.
Annual revenue - Latest available
Total funding $4.7M 2 rounds
Employees - Tracked headcount
Investors 4 Known backers
Products 1 Services tracked
Competitors 10 Brand Intelligence

About InfanDx

InfanDx is a company based in Koln (Germany) founded in 2010. InfanDx has raised $4.74 million across 2 funding rounds from investors including FIL Bros. Capital GmbH, Alluti and Bert Bleicher. InfanDx offers products and services including Neonatal Diagnostics Services. InfanDx operates in a competitive market with competitors including Roche, Cordlife, SonoSite, EKF and NVision Imaging Technologies, among others.

  • Headquarter Koln, Germany
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Infandx Ag
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $4.74 M (USD)

    in 2 rounds

  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of InfanDx

InfanDx offers a comprehensive portfolio of products and services, including Neonatal Diagnostics Services.

Product name locked
Category locked
Primary

Provides tools for neonatal health monitoring and metabolomics analysis.

People of InfanDx

Headcount 1-10
Employee Profiles 3
Board Members and Advisors 11
Employee Profiles
People
Carola Steins-Rang
Head, Clinical, Regulatory & Quality
People
Gunter Weiss
COO
People
Aisha Munk
Head, Medical Science

Unlock access to complete

Board Members and Advisors
people
Paul Owsianowski
Board Member
people
Wolfgang Schwandner
Board Member
people
Matthias Keller
Scientific Advisor
people
Lena Hellström-Westas
Scientific Advisor

Unlock access to complete

Funding Insights of InfanDx

InfanDx has successfully raised a total of $4.74M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in InfanDx

InfanDx has secured backing from 4 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include FIL Bros. Capital GmbH, Alluti and Bert Bleicher.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
A single family office focused on smart investments is operated.
Locked Locked Locked
-
Locked Locked Locked

Bert Bleicher

Angel investor focusing on Indian startups, tech enthusiast, and strategic advisor
Locked Locked Locked
Premium access

Investor details for InfanDx

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by InfanDx

Investments
Premium access

Investment portfolio details for InfanDx

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - InfanDx

Premium access

Detailed financials for InfanDx

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Infandx Comparisons

InfanDx Primary company
Description
In-vitro diagnostic products for newborn acute care conditio...
Location
Koln, Germany
Founded Year
2010
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for InfanDx

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of InfanDx

InfanDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Roche, Cordlife, SonoSite, EKF and NVision Imaging Technologies, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceuticals and diagnostics kits are developed for various diseases.
Locked Locked Locked
Cordlife is engaged in cord blood banking and diagnostics.
Locked Locked Locked
Hand-carried ultrasound systems for medical specialties are developed and distributed.
Locked Locked Locked
Point-of-care and laboratory blood analyzers are developed by EKF.
Locked Locked Locked
Medical imaging is provided through quantum technologies.
Locked Locked Locked
Drug testing services are offered for clinical trials and workplaces.
Premium access

Detailed competitors of InfanDx

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Infandx

Premium access

Complete news archive for InfanDx

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about InfanDx

InfanDx was founded in 2010 and raised its 1st funding round 11 years after it was founded.

InfanDx is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.

Achim Plum is the current CEO of InfanDx.

InfanDx is a funded company, having raised a total of $4.74M across 2 funding rounds to date.

InfanDx was founded in 2010 in Cologne, Germany, as a developer of in-vitro diagnostic products focused on acute and critical care for newborns. Operations center on tools like the HypoxE test, which identifies perinatal asphyxia from oxygen deficits at birth, assesses hypoxic-ischemic encephalopathy prognosis, and detects related brain injuries. The sector involves medical diagnostics for neonatal health challenges.

InfanDx's top competitors include Cordlife, Roche and EKF.

InfanDx offers Neonatal Diagnostics Services.

InfanDx has 4 investors. Key investors include FIL Bros. Capital GmbH, Alluti, Bert Bleicher, and Jochen Tschunke.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available